David Robert Grimes and Anjali Mahto challenge collagen skin studies

Although hydrolysed collagen supplements are increasingly popular as a skin anti-ageing measure, the current clinical evidence basis is methodically weak, inconsistent and prone to bias, biostatistician David Robert Grimes and dermatologist Anjali Mahto concluded in the Journal of Cosmetic Dermatology. Oral collagen supplements have surged into massive sales hits as consumers look for ways to maintain healthy skin and combat fine facial lines. However, a new scientific review reveals significant flaws and calculation errors in key research supporting these popular anti-ageing products.

Flaws Found in Collagen Meta-Analyses

Biostatistiker David Robert Grimes from Trinity College Dublin in Ireland and British dermatologist Anjali Mahto analyzed why research into collagen supplements against skin ageing contains major shortcomings. When reviewing two meta-analyses published in 2021 and 2023, the researchers discovered clear errors, including miscalculations in statistical measurements. After re-evaluating these data sets, they found no statistically significant link between collagen dosage and improvements in skin moisture or elasticity. The authors pointed out that many studies included in the meta-analyses were funded by the beauty industry or featured authors with commercial ties to collagen manufacturers. Furthermore, these trials often suffered from small participant pools, wide age variations, and inconsistent treatment durations.

Celebrity Endorsements Drive Market Growth

Despite the lack of robust scientific backing, demand for oral collagen powders and drinks remains exceptionally high. Young social media stars like Kylie Jenner and Hailey Bieber regularly use collagen, and their large audiences notice these habits. Dermatologist Mahto reported a rising volume of patients who either use collagen products or inquire about them during consultations. This consumer enthusiasm contrasts sharply with the limited and controversial evidence supporting actual skin benefits. At first glance, these results suggest that collagen supplements can counteract some aspects of skin ageing, Grimes and Mahto noted regarding previous positive studies. However, there are significant methodological concerns that qualify these optimistic conclusions.

Variable Dosing and Placebo Complications

Clinical studies on oral collagen face multiple experimental hurdles that distort their findings. Dosages across the reviewed literature varied dramatically, ranging from 0.3 grams to 10 grams per day, representing a more than 30-fold difference. Some studies also combined collagen with other bioactive ingredients, making it nearly impossible to isolate the specific effects of hydrolysed peptides. Additionally, clinical trials often lasted only eight to 12 weeks, and placebo formulas frequently failed because collagen possesses a distinct taste and mouthfeel that study participants could easily detect. These variables weaken the reliability of control groups and complicate efforts to prove how much ingested collagen actually reaches the skin.

Medical Recommendations Pending Rigorous Testing

Given the complexity and methodological weaknesses in existing human trials, Grimes and Mahto argue that collagen should not enter standard dermatological care until independent, rigorous testing proves its efficacy. Animal studies have demonstrated certain effects, but human data remains limited and unreliable. As long as clear evidence is lacking, the oral intake of collagen supplements should neither be recommended nor advised in dermatological practice, the experts advised. Until larger and truly independent trials emerge, dermatologists have no solid scientific foundation to promote oral collagen as a reliable anti-ageing intervention.